TreeWAS – Variant ID: rs71440053

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
O48 Prolonged pregnancy	0.013	0.987	0.000
O30-O48 Maternal care related to the fetus and amniotic cavity and possible delivery problems	0.009	0.991	0.000
O47 False labour	0.009	0.991	0.000
O43 Placental disorders	0.008	0.992	0.000
O47.0 False labour before 37 completed weeks of gestation	0.008	0.992	0.000
O42 Premature rupture of membranes	0.008	0.992	0.000
O47.9 False labour, unspecified	0.008	0.992	0.000
O30 Multiple gestation	0.008	0.992	0.000
O46 Antepartum haemorrhage, not elsewhere classified	0.008	0.992	0.000
O32 Maternal care for known or suspected malpresentation of foetus	0.007	0.993	0.000
O40 Polyhydramnios	0.007	0.993	0.000
O45 Premature separation of placenta [abruptio placentae]	0.007	0.993	0.000
O33 Maternal care for known or suspected disproportion	0.007	0.993	0.000
O31 Complications specific to multiple gestation	0.007	0.993	0.000
O43.1 Malformation of placenta	0.007	0.993	0.000
O35 Maternal care for known or suspected foetal abnormality and damage	0.007	0.993	0.000
O30.0 Twin pregnancy	0.007	0.993	0.000
O42.0 Premature rupture of membranes, onset of labour within 24 hours	0.007	0.993	0.000
O42.1 Premature rupture of membranes, onset of labour after 24 hours	0.007	0.993	0.000
O43.8 Other placental disorders	0.007	0.993	0.000
O46.8 Other antepartum haemorrhage	0.007	0.993	0.000
O44 Placenta praevia	0.006	0.994	0.000
O34 Maternal care for known or suspected abnormality of pelvic organs	0.006	0.994	0.000
O43.9 Placental disorder, unspecified	0.006	0.994	0.000
O43.2 Morbidly adherent placenta	0.006	0.994	0.000
O43.0 Placental transfusion syndromes	0.006	0.994	0.000
O41 Other disorders of amniotic fluid and membranes	0.006	0.994	0.000
O42.2 Premature rupture of membranes, labour delayed by therapy	0.006	0.994	0.000
O30.9 Multiple gestation, unspecified	0.006	0.994	0.000
O30.8 Other multiple gestation	0.006	0.994	0.000
O30.2 Quadruplet pregnancy	0.006	0.994	0.000
O30.1 Triplet pregnancy	0.006	0.994	0.000
O46.0 Antepartum haemorrhage with coagulation defect	0.006	0.994	0.000
O46.9 Antepartum haemorrhage, unspecified	0.006	0.994	0.000
O32.0 Maternal care for unstable lie	0.005	0.994	0.000
O35.9 Maternal care for (suspected) foetal abnormality and damage, unspecified	0.005	0.994	0.000
O32.4 Maternal care for high head at term	0.005	0.994	0.000
O42.9 Premature rupture of membranes, unspecified	0.005	0.995	0.000
G35 Multiple sclerosis	0.005	0.995	0.000
Z03.4 Observation for suspected myocardial infarction	0.000	0.995	0.005
O32.9 Maternal care for malpresentation of foetus, unspecified	0.005	0.995	0.000
O32.6 Maternal care for compound presentation	0.005	0.995	0.000
O32.3 Maternal care for face, brow and chin presentation	0.005	0.995	0.000
O32.2 Maternal care for transverse and oblique lie	0.005	0.995	0.000
O34.8 Maternal care for other abnormalities of pelvic organs	0.005	0.995	0.000
O32.5 Maternal care for multiple gestation with malpresentation of one foetus or more	0.005	0.995	0.000
O32.8 Maternal care for other malpresentation of foetus	0.005	0.995	0.000
O31.8 Other complications specific to multiple gestation	0.005	0.995	0.000
O31.2 Continuing pregnancy after intra-uterine death of one foetus or more	0.005	0.995	0.000
O31.1 Continuing pregnancy after abortion of one foetus or more	0.005	0.995	0.000
O31.0 Papyraceous foetus	0.005	0.995	0.000
O33.9 Maternal care for disproportion, unspecified	0.005	0.995	0.000
O33.8 Maternal care for disproportion of other origin	0.005	0.995	0.000
O33.7 Maternal care for disproportion due to other foetal deformities	0.005	0.995	0.000
O33.6 Maternal care for disproportion due to hydrocephalic foetus	0.005	0.995	0.000
O33.5 Maternal care for disproportion due to unusually large foetus	0.005	0.995	0.000
O33.4 Maternal care for disproportion of mixed maternal and foetal origin	0.005	0.995	0.000
O33.3 Maternal care for disproportion due to outlet contraction of pelvis	0.005	0.995	0.000
O33.2 Maternal care for disproportion due to inlet contraction of pelvis	0.005	0.995	0.000
O33.1 Maternal care for disproportion due to generally contracted pelvis	0.005	0.995	0.000
O33.0 Maternal care for disproportion due to deformity of maternal pelvic bones	0.005	0.995	0.000
O45.9 Premature separation of placenta, unspecified	0.005	0.995	0.000
O45.8 Other premature separation of placenta	0.005	0.995	0.000
O45.0 Premature separation of placenta with coagulation defect	0.005	0.995	0.000
O32.1 Maternal care for breech presentation	0.005	0.995	0.000
O35.8 Maternal care for other (suspected) foetal abnormality and damage	0.005	0.995	0.000
O35.7 Maternal care for (suspected) damage to foetus by other medical procedures	0.005	0.995	0.000
O35.6 Maternal care for (suspected) damage to foetus by radiation	0.005	0.995	0.000
O35.5 Maternal care for (suspected) damage to foetus by drugs	0.005	0.995	0.000
O35.4 Maternal care for (suspected) damage to foetus from alcohol	0.005	0.995	0.000
O35.3 Maternal care for (suspected) damage to foetus from viral disease in mother	0.005	0.995	0.000
O35.2 Maternal care for (suspected) hereditary disease in foetus	0.005	0.995	0.000
O35.0 Maternal care for (suspected) central nervous system malformation in foetus	0.005	0.995	0.000
O34.7 Maternal care for abnormality of vulva and perineum	0.005	0.995	0.000
O44.0 Placenta praevia specified as without haemorrhage	0.005	0.995	0.000
O34.9 Maternal care for abnormality of pelvic organ, unspecified	0.005	0.995	0.000
O34.6 Maternal care for abnormality of vagina	0.005	0.995	0.000
O34.5 Maternal care for other abnormalities of gravid uterus	0.005	0.995	0.000
O34.4 Maternal care for other abnormalities of cervix	0.005	0.995	0.000
O34.3 Maternal care for cervical incompetence	0.005	0.995	0.000
O34.0 Maternal care for congenital malformation of uterus	0.005	0.995	0.000
H02.8 Other specified disorders of eyelid	0.005	0.995	0.000
O41.9 Disorder of amniotic fluid and membranes, unspecified	0.004	0.995	0.000
O41.1 Infection of amniotic sac and membranes	0.004	0.995	0.000
O41.8 Other specified disorders of amniotic fluid and membranes	0.004	0.995	0.000
O34.2 Maternal care due to uterine scar from previous surgery	0.004	0.995	0.000
H04.2 Epiphora	0.004	0.995	0.000
G62 Other polyneuropathies	0.004	0.996	0.000
G62.0 Drug-induced polyneuropathy	0.004	0.996	0.000
O44.1 Placenta praevia with haemorrhage	0.004	0.996	0.000
O35.1 Maternal care for (suspected) chromosomal abnormality in foetus	0.004	0.996	0.000
G62.9 Polyneuropathy, unspecified	0.004	0.996	0.000
H04 Disorders of lachrymal system	0.004	0.996	0.000
O34.1 Maternal care for tumour of corpus uteri	0.004	0.996	0.000
O47.1 False labour at or after 37 completed weeks of gestation	0.004	0.996	0.000
G62.8 Other specified polyneuropathies	0.004	0.996	0.000
H04.8 Other disorders of lachrymal system	0.004	0.996	0.000
M25.55 Pain in joint (Pelvic region and thigh)	0.004	0.996	0.000
D12.0 Caecum	0.000	0.996	0.004
O41.0 Oligohydramnios	0.004	0.996	0.000
H04.9 Disorder of lachrymal system, unspecified	0.004	0.996	0.000
L98.8 Other specified disorders of skin and subcutaneous tissue	0.000	0.996	0.004
L82 Seborrhoeic keratosis	0.000	0.996	0.004
L90.0 Lichen sclerosus et atrophicus	0.000	0.996	0.003
G62.2 Polyneuropathy due to other toxic agents	0.003	0.997	0.000
G62.1 Alcoholic polyneuropathy	0.003	0.997	0.000
L90 Atrophic disorders of skin	0.000	0.997	0.003
H04.6 Other changes in lachrymal passages	0.003	0.997	0.000
H04.4 Chronic inflammation of lachrymal passages	0.003	0.997	0.000
H04.3 Acute and unspecified inflammation of lachrymal passages	0.003	0.997	0.000
H04.0 Dacryoadenitis	0.003	0.997	0.000
H00-H06 Disorders of eyelid, lacrimal system and orbit	0.003	0.997	0.000
H02 Other disorders of eyelid	0.003	0.997	0.000
H02.5 Other disorders affecting eyelid function	0.003	0.997	0.000
H04.5 Stenosis and insufficiency of lachrymal passages	0.003	0.997	0.000
G60-G64 Polyneuropathies and other disorders of the peripheral nervous system	0.003	0.997	0.000
G60 Hereditary and idiopathic neuropathy	0.003	0.997	0.000
H01 Other inflammation of eyelid	0.003	0.997	0.000
K57.9 Diverticular disease of intestine, part unspecified, without perforation or abscess	0.000	0.997	0.003
G35-G37 Demyelinating diseases of the central nervous system	0.003	0.997	0.000
L90.5 Scar conditions and fibrosis of skin	0.000	0.997	0.003
L80-L99 Other disorders of the skin and subcutaneous tissue	0.000	0.997	0.003
G60.0 Hereditary motor and sensory neuropathy	0.003	0.997	0.000
L97 Ulcer of lower limb, not elsewhere classified	0.000	0.997	0.003
A09.9 Gastroenteritis and colitis of unspecified origin	0.000	0.997	0.003
H04.1 Other disorders of lachrymal gland	0.003	0.997	0.000
H01.0 Blepharitis	0.003	0.997	0.000
L92 Granulomatous disorders of skin and subcutaneous tissue	0.000	0.997	0.003
G60.8 Other hereditary and idiopathic neuropathies	0.003	0.997	0.000
A49.0 Staphylococcal infection, unspecified	0.003	0.997	0.000
H05 Disorders of orbit	0.003	0.997	0.000
L90.9 Atrophic disorder of skin, unspecified	0.000	0.997	0.003
L90.8 Other atrophic disorders of skin	0.000	0.997	0.003
L90.6 Striae atrophicae	0.000	0.997	0.003
L90.4 Acrodermatitis chronica atrophicans	0.000	0.997	0.003
L90.3 Atrophoderma of Pasini and Pierini	0.000	0.997	0.003
L90.2 Anetoderma of Jadassohn-Pellizzari	0.000	0.997	0.003
L90.1 Anetoderma of Schweninger-Buzzi	0.000	0.997	0.003
L92.3 Foreign body granuloma of skin and subcutaneous tissue	0.000	0.997	0.003
H02.1 Ectropion of eyelid	0.003	0.997	0.000
H01.8 Other specified inflammation of eyelid	0.003	0.997	0.000
G37 Other demyelinating diseases of central nervous system	0.003	0.997	0.000
H03 Disorders of eyelid in diseases classified elsewhere	0.003	0.997	0.000
H02.7 Other degenerative disorders of eyelid and periocular area	0.003	0.997	0.000
H02.2 Lagophthalmos	0.003	0.997	0.000
G61 Inflammatory polyneuropathy	0.003	0.997	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.003	0.997	0.000
G64 Other disorders of peripheral nervous system	0.002	0.997	0.000
L81 Other disorders of pigmentation	0.000	0.997	0.003
G60.9 Hereditary and idiopathic neuropathy, unspecified	0.002	0.997	0.000
G60.3 Idiopathic progressive neuropathy	0.002	0.997	0.000
G60.2 Neuropathy in association with hereditary ataxia	0.002	0.997	0.000
G60.1 Refsum's disease	0.002	0.997	0.000
H05.2 Exophthalmic conditions	0.002	0.997	0.000
H01.9 Inflammation of eyelid, unspecified	0.002	0.997	0.000
H01.1 Non-infectious dermatoses of eyelid	0.002	0.997	0.000
H02.0 Entropion and trichiasis of eyelid	0.002	0.997	0.000
N70.1 Chronic salpingitis and oophoritis	0.000	0.997	0.002
G63 Polyneuropathy in diseases classified elsewhere	0.002	0.997	0.000
L95 Vasculitis limited to skin, not elsewhere classified	0.000	0.997	0.002
G36 Other acute disseminated demyelination	0.002	0.997	0.000
L98 Other disorders of skin and subcutaneous tissue, not elsewhere classified	0.000	0.998	0.002
L83 Acanthosis nigricans	0.000	0.998	0.002
H06 Disorders of lachrymal system and orbit in diseases classified elsewhere	0.002	0.998	0.000
L99 Other disorders of skin and subcutaneous tissue in diseases classified elsewhere	0.000	0.998	0.002
L87 Transepidermal elimination disorders	0.000	0.998	0.002
L88 Pyoderma gangrenosum	0.000	0.998	0.002
L86 Keratoderma in diseases classified elsewhere	0.000	0.998	0.002
L80 Vitiligo	0.000	0.998	0.002
L81.4 Other melanin hyperpigmentation	0.000	0.998	0.002
N03.9 Unspecified	0.000	0.998	0.002
H00 Hordeolum and chalazion	0.002	0.998	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.002	0.998	0.000
G37.9 Demyelinating disease of central nervous system, unspecified	0.002	0.998	0.000
N76.0 Acute vaginitis	0.000	0.998	0.002
L94 Other localised connective tissue disorders	0.000	0.998	0.002
F32.9 Depressive episode, unspecified	0.000	0.998	0.002
L92.9 Granulomatous disorder of skin and subcutaneous tissue, unspecified	0.000	0.998	0.002
L93 Lupus erythematosus	0.000	0.998	0.002
H02.6 Xanthelasma of eyelid	0.002	0.998	0.000
L92.8 Other granulomatous disorders of skin and subcutaneous tissue	0.000	0.998	0.002
L92.2 Granuloma faciale [eosinophilic granuloma of skin]	0.000	0.998	0.002
L92.1 Necrobiosis lipoidica, not elsewhere classified	0.000	0.998	0.002
O36 Maternal care for other known or suspected foetal problems	0.002	0.998	0.000
A49 Bacterial infection of unspecified site	0.002	0.998	0.000
A49.1 Streptococcal infection, unspecified	0.002	0.998	0.000
H05.9 Disorder of orbit, unspecified	0.002	0.998	0.000
H05.8 Other disorders of orbit	0.002	0.998	0.000
H05.5 Retained (old) foreign body following penetrating wound of orbit	0.002	0.998	0.000
H05.4 Enophthalmos	0.002	0.998	0.000
H05.3 Deformity of orbit	0.002	0.998	0.000
H05.1 Chronic inflammatory disorders of orbit	0.002	0.998	0.000
Y52 Agents primarily affecting the cardiovascular system	0.002	0.998	0.000
L84 Corns and callosities	0.000	0.998	0.002
G37.3 Acute transverse myelitis in demyelinating disease of central nervous system	0.002	0.998	0.000
G61.0 Guillain-Barre syndrome	0.002	0.998	0.000
L92.0 Granuloma annulare	0.000	0.998	0.002
G37.8 Other specified demyelinating diseases of central nervous system	0.002	0.998	0.000
G37.5 Concentric sclerosis [Balo]	0.002	0.998	0.000
G37.4 Subacute necrotising myelitis	0.002	0.998	0.000
G37.2 Central pontine myelinolysis	0.002	0.998	0.000
G37.1 Central demyelination of corpus callosum	0.002	0.998	0.000
G37.0 Diffuse sclerosis	0.002	0.998	0.000
L89 Decubitus ulcer	0.000	0.998	0.002
G61.9 Inflammatory polyneuropathy, unspecified	0.002	0.998	0.000
G61.1 Serum neuropathy	0.002	0.998	0.000
H03.8 Involvement of eyelid in other diseases classified elsewhere	0.002	0.998	0.000
H03.1 Involvement of eyelid in other infectious diseases classified elsewhere	0.002	0.998	0.000
H03.0 Parasitic infestation of eyelid in diseases classified elsewhere	0.002	0.998	0.000
L91 Hypertrophic disorders of skin	0.000	0.998	0.002
G61.8 Other inflammatory polyneuropathies	0.002	0.998	0.000
K35.9 Acute appendicitis, unspecified	0.000	0.998	0.002
L81.8 Other specified disorders of pigmentation	0.000	0.998	0.002
L81.7 Pigmented purpuric dermatosis	0.000	0.998	0.002
L81.6 Other disorders of diminished melanin formation	0.000	0.998	0.002
L81.5 Leukoderma, not elsewhere classified	0.000	0.998	0.002
L81.3 Cafe au lait spots	0.000	0.998	0.002
L81.2 Freckles	0.000	0.998	0.002
L81.1 Chloasma	0.000	0.998	0.002
L81.0 Postinflammatory hyperpigmentation	0.000	0.998	0.002
L95.9 Vasculitis limited to skin, unspecified	0.000	0.998	0.002
O36.4 Maternal care for intra-uterine death	0.002	0.998	0.000
N70 Salpingitis and oophoritis	0.000	0.998	0.002
I46.0 Cardiac arrest with successful resuscitation	0.002	0.998	0.000
G63.8 Polyneuropathy in other diseases classified elsewhere	0.002	0.998	0.000
G63.6 Polyneuropathy in other musculoskeletal disorders	0.002	0.998	0.000
G63.5 Polyneuropathy in systemic connective tissue disorders	0.002	0.998	0.000
G63.4 Polyneuropathy in nutritional deficiency	0.002	0.998	0.000
G63.3 Polyneuropathy in other endocrine and metabolic diseases	0.002	0.998	0.000
G63.1 Polyneuropathy in neoplastic disease	0.002	0.998	0.000
G63.0 Polyneuropathy in infectious and parasitic diseases classified elsewhere	0.002	0.998	0.000
L95.8 Other vasculitis limited to skin	0.000	0.998	0.002
L95.1 Erythema elevatum diutinum	0.000	0.998	0.002
L95.0 Livedoid vasculitis	0.000	0.998	0.002
G36.9 Acute disseminated demyelination, unspecified	0.002	0.998	0.000
G36.8 Other specified acute disseminated demyelination	0.002	0.998	0.000
G36.1 Acute and subacute haemorrhagic leukoencephalitis [Hurst]	0.002	0.998	0.000
G36.0 Neuromyelitis optica [Devic]	0.002	0.998	0.000
N76 Other inflammation of vagina and vulva	0.000	0.998	0.002
H05.0 Acute inflammation of orbit	0.002	0.998	0.000
H06.3 Other disorders of orbit in diseases classified elsewhere	0.002	0.998	0.000
H06.1 Parasitic infestation of orbit in diseases classified elsewhere	0.002	0.998	0.000
H06.0 Disorders of lachrymal system in diseases classified elsewhere	0.002	0.998	0.000
L87.9 Transepidermal elimination disorder, unspecified	0.000	0.998	0.002
L87.8 Other transepidermal elimination disorders	0.000	0.998	0.002
L87.2 Elastosis perforans serpiginosa	0.000	0.998	0.002
L87.1 Reactive perforating collagenosis	0.000	0.998	0.002
L87.0 Keratosis follicularis et parafollicularis in cutem penetrans [Kyrle]	0.000	0.998	0.002
L98.7 Excessive and redundant skin and subcutaneous tissue	0.000	0.998	0.002
L98.6 Other infiltrative disorders of skin and subcutaneous tissue	0.000	0.998	0.002
L98.5 Mucinosis of skin	0.000	0.998	0.002
L98.3 Eosinophilic cellulitis [Wells]	0.000	0.998	0.002
L98.2 Febrile neutrophilic dermatosis [Sweet]	0.000	0.998	0.002
L98.1 Factitial dermatitis	0.000	0.998	0.002
L99.8 Other specified disorders of skin and subcutaneous tissue in diseases classified elsewhere	0.000	0.998	0.002
L99.0 Amyloidosis of skin	0.000	0.998	0.002
N76.4 Abscess of vulva	0.000	0.998	0.002
H02.4 Ptosis of eyelid	0.002	0.998	0.000
L85 Other epidermal thickening	0.000	0.998	0.002
G63.2 Diabetic polyneuropathy	0.002	0.998	0.000
L89.9 Decubitus ulcer and pressure area, unspecified	0.000	0.998	0.002
L94.9 Localised connective tissue disorder, unspecified	0.000	0.998	0.002
L94.8 Other specified localised connective tissue disorders	0.000	0.998	0.002
L94.6 Ainhum	0.000	0.998	0.002
L94.5 Poikiloderma vasculare atrophicans	0.000	0.998	0.002
L94.4 Gottron's papules	0.000	0.998	0.002
L94.3 Sclerodactyly	0.000	0.998	0.002
L94.2 Calcinosis cutis	0.000	0.998	0.002
L94.1 Linear scleroderma	0.000	0.998	0.002
N70.9 Salpingitis and oophoritis, unspecified	0.000	0.998	0.002
H00.0 Hordeolum and other deep inflammation of eyelid	0.002	0.998	0.000
L93.2 Other local lupus erythematosus	0.000	0.998	0.002
L93.1 Subacute cutaneous lupus erythematosus	0.000	0.998	0.002
O36.7 Maternal care for viable foetus in abdominal pregnancy	0.002	0.998	0.000
O36.3 Maternal care for signs of foetal hypoxia	0.002	0.998	0.000
O36.2 Maternal care for hydrops foetalis	0.002	0.998	0.000
O36.1 Maternal care for other isoimmunisation	0.002	0.998	0.000
L91.0 Keloid scar	0.000	0.998	0.002
A49.3 Mycoplasma infection, unspecified	0.002	0.998	0.000
A49.2 Haemophilus influenzae infection, unspecified	0.002	0.998	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.002	0.998	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.002	0.998	0.000
Y52.7 Peripheral vasodilators	0.002	0.998	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.002	0.998	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.002	0.998	0.000
Y52.1 Calcium-channel blockers	0.002	0.998	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.002	0.998	0.000
M71.26 Synovial cyst of popliteal space [Baker]-Lower Leg	0.002	0.998	0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.002	0.998	0.000
A09 Diarrhoea and gastro-enteritis of presumed infectious origin	0.000	0.998	0.002
A49.8 Other bacterial infections of unspecified site	0.002	0.998	0.000
H33.3 Retinal breaks without detachment	0.002	0.998	0.000
L94.0 Localised scleroderma [morphea]	0.000	0.998	0.002
N76.8 Other specified inflammation of vagina and vulva	0.000	0.998	0.002
A49.9 Bacterial infection, unspecified	0.002	0.998	0.000
H06.2 Dysthyroid exophthalmos	0.002	0.998	0.000
L81.9 Disorder of pigmentation, unspecified	0.000	0.998	0.002
L89.2 Stage III decubitus ulcer	0.000	0.998	0.002
M10.99 Gout, unspecified (Site unspecified)	0.000	0.998	0.002
L89.3 Stage IV decubitus ulcer	0.000	0.998	0.002
L91.9 Hypertrophic disorder of skin, unspecified	0.000	0.998	0.002
Y40.8 Other systemic antibiotics	0.002	0.998	0.000
Y49.5 Other antipsychotics and neuroleptics	0.002	0.998	0.000
Y40 Systemic antibiotics	0.002	0.998	0.000
G20 Parkinson's disease	0.002	0.998	0.000
L93.0 Discoid lupus erythematosus	0.000	0.998	0.002
N70.0 Acute salpingitis and oophoritis	0.000	0.998	0.002
N76.6 Ulceration of vulva	0.000	0.998	0.002
N76.5 Ulceration of vagina	0.000	0.998	0.002
N76.3 Subacute and chronic vulvitis	0.000	0.998	0.002
N76.1 Subacute and chronic vaginitis	0.000	0.998	0.002
A09.0 Other and unspecified gastroenteritis and colitis of infectious origin	0.000	0.998	0.002
L89.0 Stage I decubitus ulcer and pressure area	0.000	0.998	0.002
C50.2 Upper-inner quadrant of breast	0.002	0.998	0.000
L85.3 Xerosis cutis	0.000	0.998	0.002
L85.2 Keratosis punctata (palmaris et plantaris)	0.000	0.998	0.002
L85.1 Acquired keratosis [keratoderma] palmaris et plantaris	0.000	0.998	0.002
L85.0 Acquired ichthyosis	0.000	0.998	0.002
Y52.4 Angiotensin-converting-enzyme inhibitors	0.002	0.998	0.000
Z85.3 Personal history of malignant neoplasm of breast	0.002	0.998	0.000
H00.1 Chalazion	0.002	0.998	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
L98.4 Chronic ulcer of skin, not elsewhere classified	0.000	0.998	0.001
H02.3 Blepharochalasis	0.002	0.998	0.000
H65.3 Chronic mucoid otitis media	0.002	0.998	0.000
H65.0 Acute serous otitis media	0.002	0.998	0.000
Y40.9 Systemic antibiotic, unspecified	0.002	0.998	0.000
R13 Dysphagia	0.000	0.998	0.002
C50.0 Nipple and areola	0.002	0.998	0.000
O36.6 Maternal care for excessive foetal growth	0.001	0.998	0.000
N77.1 Vaginitis, vulvitis and vulvovaginitis in infectious and parasitic diseases classified elsewhere	0.000	0.998	0.002
O36.5 Maternal care for poor foetal growth	0.001	0.998	0.000
D05.1 Intraductal carcinoma in situ	0.002	0.998	0.000
O36.9 Maternal care for foetal problem, unspecified	0.001	0.998	0.001
Y40.1 Cefalosporins and other -lactam antibiotics	0.001	0.998	0.000
Y40.0 Penicillins	0.002	0.998	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.002	0.998	0.000
C34.3 Lower lobe, bronchus or lung	0.000	0.998	0.002
O00.1 Tubal pregnancy	0.002	0.998	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.002	0.998	0.000
L85.9 Epidermal thickening, unspecified	0.000	0.998	0.001
Y40.7 Antifungal antibiotics, systemically used	0.001	0.998	0.000
Y40.6 Rifamycins	0.001	0.998	0.000
Y40.5 Aminoglycosides	0.001	0.998	0.000
Y40.4 Tetracyclines	0.001	0.998	0.000
Y40.3 Macrolides	0.001	0.998	0.000
Y40.2 Chloramphenicol group	0.001	0.998	0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.001	0.998	0.000
Z91.5 Personal history of self-harm	0.000	0.998	0.002
A46 Erysipelas	0.002	0.998	0.000
N77 Vulvovaginal ulceration and inflammation in diseases classified elsewhere	0.000	0.998	0.002
Y48 Anaesthetics and therapeutic gases	0.001	0.998	0.000
N76.2 Acute vulvitis	0.000	0.998	0.001
O36.0 Maternal care for rhesus isoimmunisation	0.001	0.998	0.000
Z39.0 Care and examination immediately after delivery	0.002	0.998	0.000
Y48.4 Anaesthetic, unspecified	0.001	0.998	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.001	0.998	0.000
H65 Nonsuppurative otitis media	0.002	0.998	0.000
H02.9 Disorder of eyelid, unspecified	0.001	0.998	0.000
J38.0 Paralysis of vocal cords and larynx	0.000	0.998	0.001
Y49.9 Psychotropic drug, unspecified	0.001	0.998	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.001	0.998	0.000
Y49.7 Psychostimulants with abuse potential	0.001	0.998	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.001	0.998	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.001	0.998	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.001	0.998	0.000
Y49.2 Other and unspecified antidepressants	0.001	0.998	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.001	0.998	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.001	0.998	0.000
N70-N77 Inflammatory diseases of female pelvic organs	0.000	0.998	0.002
A40 Streptococcal septicaemia	0.001	0.998	0.000
A30-A49 Other bacterial diseases	0.001	0.998	0.000
L98.0 Pyogenic granuloma	0.000	0.999	0.001
M25.78 Osteophyte (Other)	0.000	0.999	0.001
C50.5 Lower-outer quadrant of breast	0.001	0.999	0.000
G30.9 Alzheimer's disease, unspecified	0.000	0.999	0.001
A40.8 Other streptococcal septicaemia	0.001	0.999	0.000
H65.9 Nonsuppurative otitis media, unspecified	0.001	0.999	0.000
Y42.0 Glucocorticoids and synthetic analogs	0.001	0.999	0.000
N13.4 Hydroureter	0.001	0.999	0.000
Q24.9 Congenital malformation of the heart, unspecified	0.001	0.999	0.000
Y59 Other and unspecified vaccines and biological substances	0.001	0.999	0.000
Y58 Bacterial vaccines	0.001	0.999	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.001	0.999	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.001	0.999	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.001	0.999	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.001	0.999	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.001	0.999	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.001	0.999	0.000
A40.9 Streptococcal septicaemia, unspecified	0.001	0.999	0.000
C50.9 Breast, unspecified	0.001	0.999	0.000
H65.4 Other chronic nonsuppurative otitis media	0.001	0.999	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.001	0.999	0.000
Y41.5 Antiviral drugs	0.001	0.999	0.000
Y41.4 Anthelminthics	0.001	0.999	0.000
Y41.3 Other antiprotozoal drugs	0.001	0.999	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.001	0.999	0.000
Y41.1 Antimycobacterial drugs	0.001	0.999	0.000
Y41.0 Sulphonamides	0.001	0.999	0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.001	0.999	0.000
L85.8 Other specified epidermal thickening	0.000	0.999	0.001
N77.8 Vulvovaginal ulceration and inflammation in other diseases classified elsewhere	0.000	0.999	0.001
N77.0 Ulceration of vulva in infectious and parasitic diseases classified elsewhere	0.000	0.999	0.001
Y48.5 Therapeutic gases	0.001	0.999	0.000
Y48.3 Local anaesthetics	0.001	0.999	0.000
Y48.2 Other and unspecified general anaesthetics	0.001	0.999	0.000
Y48.1 Parenteral anaesthetics	0.001	0.999	0.000
Y48.0 Inhaled anaesthetics	0.001	0.999	0.000
E10.1 With ketoacidosis	0.001	0.999	0.000
L89.1 Stage II decubitus ulcer	0.000	0.999	0.001
Y42.9 Other and unspecified hormone antagonists	0.001	0.999	0.000
Y42.4 Oral contraceptives	0.001	0.999	0.000
Y42.2 Antithyroid drugs	0.001	0.999	0.000
Y42.1 Thyroid hormones and substitutes	0.001	0.999	0.000
N03 Chronic nephritic syndrome	0.000	0.999	0.001
H65.2 Chronic serous otitis media	0.001	0.999	0.000
H65.1 Other acute nonsuppurative otitis media	0.001	0.999	0.000
A40.2 Septicaemia due to streptococcus, group D	0.001	0.999	0.000
A40.1 Septicaemia due to streptococcus, group B	0.001	0.999	0.000
A40.0 Septicaemia due to streptococcus, group A	0.001	0.999	0.000
C50 Malignant neoplasm of breast	0.001	0.999	0.000
N74 Female pelvic inflammatory disorders in diseases classified elsewhere	0.000	0.999	0.001
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.001	0.999	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.001	0.999	0.000
M10.97 Gout, unspecified (Ankle and foot)	0.000	0.999	0.001
A48 Other bacterial diseases, not elsewhere classified	0.001	0.999	0.000
A44 Bartonellosis	0.001	0.999	0.000
A43 Nocardiosis	0.001	0.999	0.000
A42 Actinomycosis	0.001	0.999	0.000
A39 Meningococcal infection	0.001	0.999	0.000
A37 Whooping cough	0.001	0.999	0.000
A36 Diphtheria	0.001	0.999	0.000
A32 Listeriosis	0.001	0.999	0.000
A31 Infection due to other mycobacteria	0.001	0.999	0.000
A30 Leprosy [Hansen's disease]	0.001	0.999	0.000
A38 Scarlet fever	0.001	0.999	0.000
A35 Other tetanus	0.001	0.999	0.000
A34 Obstetrical tetanus	0.001	0.999	0.000
A33 Tetanus neonatorum	0.001	0.999	0.000
M25.75 Osteophyte (Pelvic region and thigh)	0.000	0.999	0.001
A40.3 Septicaemia due to Streptococcus pneumoniae	0.001	0.999	0.000
T14.0 Superficial injury of unspecified body region	0.001	0.999	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.001	0.999	0.000
Y57 Other and unspecified drugs and medicaments	0.001	0.999	0.000
M10.9 Gout, unspecified	0.000	0.999	0.001
N81.2 Incomplete uterovaginal prolapse	0.000	0.999	0.001
Y46.8 Antispasticity drugs	0.001	0.999	0.000
Y46.7 Anti-Parkinsonism drugs	0.001	0.999	0.000
Y46.6 Other and unspecified antiepileptics	0.001	0.999	0.000
Y46.5 Valproic acid	0.001	0.999	0.000
Y46.4 Iminostilbenes	0.001	0.999	0.000
Y46.3 Deoxybarbiturates	0.001	0.999	0.000
Y46.2 Hydantoin derivatives	0.001	0.999	0.000
Y46.1 Oxazolidinediones	0.001	0.999	0.000
Y46.0 Succinimides	0.001	0.999	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.001	0.999	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.001	0.999	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.001	0.999	0.000
Y47.4 Bromine compounds	0.001	0.999	0.000
Y47.3 Paraldehyde	0.001	0.999	0.000
Y47.2 Chloral derivatives	0.001	0.999	0.000
Y47.1 Benzodiazepines	0.001	0.999	0.000
Y47.0 Barbiturates, not elsewhere classified	0.001	0.999	0.000
Y50.9 Central nervous system stimulant, unspecified	0.001	0.999	0.000
Y50.8 Other central nervous system stimulants	0.001	0.999	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.001	0.999	0.000
Y50.1 Opioid receptor antagonists	0.001	0.999	0.000
Y50.0 Analeptics	0.001	0.999	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.001	0.999	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.001	0.999	0.000
Y53.7 Emetics	0.001	0.999	0.000
Y53.6 Antidiarrhoeal drugs	0.001	0.999	0.000
Y53.5 Digestants	0.001	0.999	0.000
Y53.4 Other laxatives	0.001	0.999	0.000
Y53.3 Saline and osmotic laxatives	0.001	0.999	0.000
Y53.2 Stimulant laxatives	0.001	0.999	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.001	0.999	0.000
Y53.0 Histamine H2-receptor antagonists	0.001	0.999	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.001	0.999	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.001	0.999	0.000
Y55.5 Anticommon cold drugs	0.001	0.999	0.000
Y55.4 Expectorants	0.001	0.999	0.000
Y55.3 Antitussives	0.001	0.999	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.001	0.999	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.001	0.999	0.000
Y55.0 Oxytocic drugs	0.001	0.999	0.000
Y56.9 Topical agent, unspecified	0.001	0.999	0.000
Y56.8 Other topical agents	0.001	0.999	0.000
Y56.7 Dental drugs, topically applied	0.001	0.999	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.001	0.999	0.000
Y56.5 Ophthalmological drugs and preparations	0.001	0.999	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.001	0.999	0.000
Y56.3 Emollients, demulcents and protectants	0.001	0.999	0.000
Y56.2 Local astringents and local detergents	0.001	0.999	0.000
Y56.1 Antipruritics	0.001	0.999	0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.001	0.999	0.000
Y58.9 Other and unspecified bacterial vaccines	0.001	0.999	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.001	0.999	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.001	0.999	0.000
Y58.5 Diphtheria vaccine	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations